U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251803) titled 'GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound' on Nov. 11.
Brief Summary: This study will enroll patients 18 years and older who are taking a GLP-1/GIP medication and 1) are scheduled for elective surgery and meet ASA fasting guidelines (nothing by mouth for at least 8 hours prior), or 2) scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior. Participants will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The purpose of this study is to determine if people taking GLP-1 receptor agonists and who fast normally are at an equal risk for...